Cargando…
Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
BACKROUND: The emergence of Mycobacterium tuberculosis strains resistant to antituberculosis agents has recently received increased attention owing largely to the dramatic outbreaks of multi drug resistance tuberculosis (MDR-TB). METHODS: Patients residing in Zonguldak and Kayseri provinces of Turke...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149381/ https://www.ncbi.nlm.nih.gov/pubmed/12537590 http://dx.doi.org/10.1186/1476-0711-1-6 |
_version_ | 1782120624882188288 |
---|---|
author | Kart, Levent Altın, Remzi Tor, Meltem Gulmez, Inci Oymak, Sema F Atmaca, Hulusi M Erdem, Funda |
author_facet | Kart, Levent Altın, Remzi Tor, Meltem Gulmez, Inci Oymak, Sema F Atmaca, Hulusi M Erdem, Funda |
author_sort | Kart, Levent |
collection | PubMed |
description | BACKROUND: The emergence of Mycobacterium tuberculosis strains resistant to antituberculosis agents has recently received increased attention owing largely to the dramatic outbreaks of multi drug resistance tuberculosis (MDR-TB). METHODS: Patients residing in Zonguldak and Kayseri provinces of Turkey with, pulmonary tuberculosis diagnosed between 1972 and 1999 were retrospectively identified. Drug susceptibility tests had been performed for isoniazid (INH), rifampin (RIF), streptomycin (SM), ethambutol (EMB) and thiacetasone (TH) after isolation by using the resistance proportion method. RESULTS: Total 3718 patients were retrospectively studied. In 1972–1981, resistance rates for to SM and INH were found to be 14.8% and 9.8% respectively (n: 2172). In 1982–1991 period, resistance rates for INH, SM, RIF, EMB and TH were 14.2%, 14.4%, 10.5%, 2.7% and 2.9% (n: 683), while in 1992–1999 period 14.4%, 21.1%, 10.6%, 2.4% and 3.7% respectively (n: 863). Resistance rates were highest for SM and INH in three periods. MDR-TB patients constituted 7.3% and 6.6% of 1982–1991 and 1992–1999 periods (p > 0.05). CONCLUSION: This study demonstrates the importance of resistance rates for TB. Continued surveillance and immediate therapeutic decisions should be undertaken in order to prevent the dissemination of such resistant strains. |
format | Text |
id | pubmed-149381 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-1493812003-02-25 Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis Kart, Levent Altın, Remzi Tor, Meltem Gulmez, Inci Oymak, Sema F Atmaca, Hulusi M Erdem, Funda Ann Clin Microbiol Antimicrob Research BACKROUND: The emergence of Mycobacterium tuberculosis strains resistant to antituberculosis agents has recently received increased attention owing largely to the dramatic outbreaks of multi drug resistance tuberculosis (MDR-TB). METHODS: Patients residing in Zonguldak and Kayseri provinces of Turkey with, pulmonary tuberculosis diagnosed between 1972 and 1999 were retrospectively identified. Drug susceptibility tests had been performed for isoniazid (INH), rifampin (RIF), streptomycin (SM), ethambutol (EMB) and thiacetasone (TH) after isolation by using the resistance proportion method. RESULTS: Total 3718 patients were retrospectively studied. In 1972–1981, resistance rates for to SM and INH were found to be 14.8% and 9.8% respectively (n: 2172). In 1982–1991 period, resistance rates for INH, SM, RIF, EMB and TH were 14.2%, 14.4%, 10.5%, 2.7% and 2.9% (n: 683), while in 1992–1999 period 14.4%, 21.1%, 10.6%, 2.4% and 3.7% respectively (n: 863). Resistance rates were highest for SM and INH in three periods. MDR-TB patients constituted 7.3% and 6.6% of 1982–1991 and 1992–1999 periods (p > 0.05). CONCLUSION: This study demonstrates the importance of resistance rates for TB. Continued surveillance and immediate therapeutic decisions should be undertaken in order to prevent the dissemination of such resistant strains. BioMed Central 2002-12-16 /pmc/articles/PMC149381/ /pubmed/12537590 http://dx.doi.org/10.1186/1476-0711-1-6 Text en Copyright © 2002 Kart et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
spellingShingle | Research Kart, Levent Altın, Remzi Tor, Meltem Gulmez, Inci Oymak, Sema F Atmaca, Hulusi M Erdem, Funda Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis |
title | Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis |
title_full | Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis |
title_fullStr | Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis |
title_full_unstemmed | Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis |
title_short | Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis |
title_sort | antituberculosis drug resistance patterns in two regions of turkey: a retrospective analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149381/ https://www.ncbi.nlm.nih.gov/pubmed/12537590 http://dx.doi.org/10.1186/1476-0711-1-6 |
work_keys_str_mv | AT kartlevent antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis AT altınremzi antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis AT tormeltem antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis AT gulmezinci antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis AT oymaksemaf antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis AT atmacahulusim antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis AT erdemfunda antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis |